光学临床前影像市场规模、份额、成长分析、按产品类型、最终用途划分 - 产业预测，2024-2031 年

Optical Preclinical Imaging Market Size, Share, Growth Analysis, By Product Type(Device, consumable), By End Use(Pharma & BioTech, Research Institute) - Industry Forecast 2024-2031

出版日期: 2024年06月04日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球光学临床前影像市场规模预估为40.5亿美元，预测期间（2024-2031年）复合年增长率为4.74%，从2023年的42.4亿美元至2031年预计将成长至61.4亿美元。

近年来，全球光学临床前影像市场对临床前测试中尖端成像技术的需求激增。这一增长的推动因素包括製药和生物技术领域研发力度的加强、对个人化医疗的日益关注以及临床前研究中早期疾病检测的需求。生物发光和萤光成像等光学成像方法为研究人员提供了生物过程的非侵入性、高保真可视化，从而提高了他们监测疾病进展和治疗效果的能力。然而，成像系统的高成本以及在临床前研究中使用动物的伦理考虑等挑战可能会阻碍市场扩张。然而，持续的技术进步、创新成像剂的出现以及教育和研究设施的激增正在为光学临床前成像市场的快速发展做出重大贡献。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

PerkinElmer, Inc.（US）
Bruker Corporation（US）
FUJIFILM Holdings Corporation（Japan）
Mediso Ltd.（Hungary）
MILabs BV（Netherlands）
MR Solutions Ltd.（UK）
LI-COR Biosciences（US）
Aspect Imaging Ltd.（Israel）
TriFoil Imaging（US）
Miltenyi Biotech GmbH（Germany）
Hamamatsu Photonics KK（Japan）
PerkinElmer, Inc.（US）-Vivo Biosciences Division
Caliper Life Sciences（US）
Xenogen Corporation（US）
IVIS Imaging Solutions（Canada）
PerkinElmer, Inc.（US）-Molecular Devices Division
GE Healthcare（US）
Siemens Healthineers（Germany）
Olympus Corporation（Japan）
Carl Zeiss AG（Germany）

简介目录

Product Code: SQMIG35A2798

Global Optical Preclinical Imaging Market size was valued at USD 4.05 billion in 2022 and is poised to grow from USD 4.24 billion in 2023 to USD 6.14 billion by 2031, at a CAGR of 4.74% during the forecast period (2024-2031).

In recent years, the global Optical Preclinical Imaging market has witnessed a surge in demand for cutting-edge imaging technology within preclinical studies. This growth is propelled by factors like intensified research and development endeavors in pharmaceutical and biotechnology sectors, a burgeoning focus on personalized medicine, and the imperative for early disease detection in preclinical investigations. Optical imaging modalities, such as bioluminescence and fluorescence imaging, offer researchers non-invasive and high-fidelity visualization of biological processes, thereby enhancing their capacity to monitor disease progression and treatment effectiveness. Nevertheless, challenges like the steep cost of imaging systems and ethical considerations surrounding animal usage in preclinical research might impede market expansion. Nonetheless, ongoing technological advancements, the emergence of innovative imaging agents, and the proliferation of educational and research establishments contribute significantly to the ever-evolving landscape of the Optical Preclinical Imaging market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Optical Preclinical Imaging Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Optical Preclinical Imaging Market Segmental Analysis

The global Optical Preclinical Imaging market is segmented into four major segments i.e. by Product Type, End-use, and region. Based on Product type, it is divided into Device, Consumable and Bioluminescence. Based on End Use, it is bifurcated as Pharma and Biotech company and research institute. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.

Drivers of the Global Optical Preclinical Imaging Market

The pharmaceutical and biotechnological sectors are witnessing a surge in the need for cutting-edge imaging technology for preclinical research. Optical imaging methods, including bioluminescence and fluorescence imaging, offer non-invasive and high-resolution visualization of biological processes, equipping researchers with crucial insights into disease advancement and the effectiveness of treatments.

Restraints in the Global Optical Preclinical Imaging Market

One of the main constraints in the market lies in the high prices of devices, creating a significant obstacle that limits access to advanced imaging technology, especially for smaller research institutions and budget-constrained companies. Ethical concerns regarding the use of animals in preclinical studies also present challenges, leading researchers to seek alternative approaches or adhere closely to strict regulatory guidelines.

Market Trends of the Global Optical Preclinical Imaging Market

There is an increasing emphasis on multimodal imaging, where various optical imaging techniques are combined to gather comprehensive and complementary data, boosting the depth and precision of preclinical investigations. Additionally, there is a rising trend in enhancing advanced imaging technologies, such as fluorescent probes and bioluminescent markers, enabling more precise and targeted visualization of biological processes.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Value Chain Analysis
Pricing Analysis
Start Up Analysis
Regulatory Landscape
Patent Analysis
Pipeline Analysis
Key Success Factors
Market Attractiveness Index
Degree of Competition
Top Investment Pockets
Ecosystem Mapping

Optical Preclinical Imaging Market by Product

Market Overview
Device
consumable
Bioluminescence

Optical Preclinical Imaging Market by End Use

Market Overview
Pharma & BioTech
Research Institute

Optical Preclinical Imaging Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

PerkinElmer, Inc. (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bruker Corporation (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
FUJIFILM Holdings Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mediso Ltd. (Hungary)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MILabs B.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MR Solutions Ltd. (U.K.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LI-COR Biosciences (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aspect Imaging Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TriFoil Imaging (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Miltenyi Biotech GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hamamatsu Photonics K.K. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (U.S.) - Vivo Biosciences Division
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Caliper Life Sciences (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Xenogen Corporation (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IVIS Imaging Solutions (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (U.S.) - Molecular Devices Division
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Olympus Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Carl Zeiss AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments